Search results for drug-safety
On March 31, 2008, at the American College of Cardiology's annual meeting, a recent analysis of several studies involving Pfizer Inc.'s arthritis drug Celebrex was presented.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The FDA added a page that gives definitions for some important terms used in the realm of prescription drug safety, and a page that is intended to assist one when researching medication safety issues
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Each year the FDA issues a so-called "report card" on how the pharmaceutical companies are doing as regards post-approval studies for their products that have been approved for sale in the U.S.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The facts surrounding the late April 2008 recall of Digitek (digoxin) pills that may have twice the active ingredient is becoming less clear as we learn more in the days following the FDA recall.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Actavis, Mylan, Or The FDA Should Tell Public Their Current Estimate Of How Many Defective Digitek Pills Were Distributed To Pharmacies, And During What Time Period
read more »
Add this link to...
Bury
Add to:
| Bookmarks
A study published in June 2008 by the Canadian Medical Association Journal which concerned 1,017 patients who presented at the Vancouver General Hospital emergency room (ER) during a 12-week period ba...
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The FDA has started an investigation into the potential link between certain TNF blockers used to treat Juvenile Idiopathic Arthritis (JIA), Crohn’s disease, or other diseases and the development of
read more »
Add this link to...
Bury
Add to:
| Bookmarks